Cheryl Harris, MD | |
2150 25th St Ste B, Columbus, IN 47201-3243 | |
(812) 376-9219 | |
(812) 378-4821 |
Full Name | Cheryl Harris |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 2150 25th St Ste B, Columbus, Indiana |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841225075 | NPI | - | NPPES |
000000984525 | Other | IN | ANTHEM PIN |
100358600 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 10341111 (Indiana) | Primary |
Entity Name | Columbus Regional Health Physicians Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336510098 PECOS PAC ID: 1052612314 Enrollment ID: O20151211000054 |
News Archive
Abbott announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for CREON® (pancrelipase) Delayed-Release Capsules that now includes dosing guidance in the prescribing information specific to patients with limited production of enzymes in the pancreas (exocrine pancreatic insufficiency) due to chronic pancreatitis (CP) or removal of the pancreas (pancreatectomy). Prior to this FDA approval, dosing guidance for medications such as CREON was based on patients with cystic fibrosis.
Pharma Major Lupin Limited announced today that it has received final approval for its supplemental New Drug Application for Antara (Fenofibrate) capsules, 30 mg & 90 mg strengths from the United States Food and Drug Administration.
About one-third of colorectal cancers are inherited, but the genetic cause of most of these cancers is unknown. The genes linked to colorectal cancer account for less than 5 percent of all cases.
Game theory can be utilized to identify potential flaws in current cancer treatment approaches and suggest new strategies to improve outcomes in patients with metastatic cancer, according to a new article published online today by JAMA Oncology.
Measuring the amount of protein lost in the urine can identify individuals at risk of developing kidney disease, according to a study appearing in the April 2009 issue of the Journal of the American Society Nephrology (JASN).
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Cheryl Harris, MD Po Box 775383, Chicago, IL 60677-5383 Ph: (812) 376-5315 | Cheryl Harris, MD 2150 25th St Ste B, Columbus, IN 47201-3243 Ph: (812) 376-9219 |
News Archive
Abbott announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for CREON® (pancrelipase) Delayed-Release Capsules that now includes dosing guidance in the prescribing information specific to patients with limited production of enzymes in the pancreas (exocrine pancreatic insufficiency) due to chronic pancreatitis (CP) or removal of the pancreas (pancreatectomy). Prior to this FDA approval, dosing guidance for medications such as CREON was based on patients with cystic fibrosis.
Pharma Major Lupin Limited announced today that it has received final approval for its supplemental New Drug Application for Antara (Fenofibrate) capsules, 30 mg & 90 mg strengths from the United States Food and Drug Administration.
About one-third of colorectal cancers are inherited, but the genetic cause of most of these cancers is unknown. The genes linked to colorectal cancer account for less than 5 percent of all cases.
Game theory can be utilized to identify potential flaws in current cancer treatment approaches and suggest new strategies to improve outcomes in patients with metastatic cancer, according to a new article published online today by JAMA Oncology.
Measuring the amount of protein lost in the urine can identify individuals at risk of developing kidney disease, according to a study appearing in the April 2009 issue of the Journal of the American Society Nephrology (JASN).
› Verified 1 days ago
Chong B Kim, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3585 Woodfield Pl, Columbus, IN 47203 Phone: 812-379-2834 | |
Nicole Lurline Mensah-pike, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2150 25th St Ste B, Columbus, IN 47201 Phone: 812-376-9219 | |
Peter M O'day, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-379-4441 | |
Kathryn Mcaleese, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1120 N Marr Rd, Columbus, IN 47201 Phone: 812-376-9219 Fax: 812-378-4821 | |
Jennifer R. Hartwell, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2150 25th St Ste B, Columbus, IN 47201 Phone: 812-376-9219 Fax: 812-378-4821 | |
Dr. Linda B Guse, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4225 Vickers Dr, Columbus, IN 47203 Phone: 812-379-9524 Fax: 812-376-6383 | |
Stephen R. Loheide, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1120 N Marr Rd, Columbus, IN 47201 Phone: 812-376-9219 Fax: 812-378-4821 |